Skip to Content
Merck
All Photos(2)

Key Documents

917230

Sigma-Aldrich

NanoFabTx device accessory

interface H

Synonym(s):

Microfluidic kit, NanoFabTx, Nanoformulation

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41121800
NACRES:
NA.23

description

Microfludic hardware kit component
Kit components : Inerface H x 1

Quality Level

application(s)

advanced drug delivery

Looking for similar products? Visit Product Comparison Guide

General description

NanoFabTx device accessory, interface H is a component of our NanoFabTx microfluidic device kits (911593, 911879). The kits additionally include a protocol, microfluidic chip, connectors, tubing, and additional accessories for microfluidic-based synthesis.

Application

NanoFabTx device accessory, interface H facilitates fluidic connections from two linear connectors to the microfluidic chip. NanoFabTx device accessory, interface H can be used as a replacement for the component in our NanoFabTx microfluidic device kits (911593, 911879).

Legal Information

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service